Evidence map›Paper›PMID 40141350›Full record

ArticleInternational journal of molecular sciences2025

A Comparative Genomic Analysis of Epstein-Barr Virus Strains with a Focus on EBV2 Variability.

Ana Catalina Blazquez, María Dolores Fellner, Mario Alejandro Lorenzetti, María Victoria Preciado

Abstract readComparative Study
In one paragraph

Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Ana Catalina BlazquezLaboratorio de Biología Molecular, División Patología, Instituto Multidisciplinario de Investigaciones en Patologías Pediátricas (IMIPP), CONICET-GCBA, Buenos Aires C1425EFD, Argentina.
María Dolores FellnerServicio Virus Oncogénicos, Laboratorio Nacional de Referencia de Virus Epstein-Barr, Departamento Virología, Instituto Nacional de Enfermedades Infecciosas (INEI)-ANLIS, "Dr C. Malbrán", Buenos Aires C1425EFD, Argentina.
Mario Alejandro LorenzettiLaboratorio de Biología Molecular, División Patología, Instituto Multidisciplinario de Investigaciones en Patologías Pediátricas (IMIPP), CONICET-GCBA, Buenos Aires C1425EFD, Argentina.
María Victoria PreciadoLaboratorio de Biología Molecular, División Patología, Instituto Multidisciplinario de Investigaciones en Patologías Pediátricas (IMIPP), CONICET-GCBA, Buenos Aires C1425EFD, Argentina.ORCID 0000-0003-4082-0698

Funding

Agencia Nacional de Promoción de la Investigación, el Desarrollo Tecnológico y la Innovación PICT 2020 Nº 00854Agencia Nacional de Promoción de la Investigación, el Desarrollo Tecnológico y la Innovación PICT 2021 Nº 00121Agencia Nacional de Promoción de la Investigación, el Desarrollo Tecnológico y la Innovación PUE 2018 0058
6 · The paper itself

Abstract

Most genomic studies on Epstein-Barr virus variability have focused on the geographic and pathological associations of EBV1 genomes. In contrast, the variability of EBV2 genomes has been less explored, mainly due to their restricted geographic circulation and the lesser number of sequenced EBV2 isolates. In this study, we sequenced and analyzed twenty-eight EBV1 and ten EBV2 genomes and a potential recombinant from Argentina, which were combined with two-hundred-and-thirty-nine downloaded complete genomes from other geographic regions, to produce an initial

Indexed as

Epstein-Barr Virus InfectionsGenetic VariationGenome, ViralGenomicsHerpesvirus 4, HumanHumansPhylogenyViral ProteinsViral ProteinsEBV2Epstein–Barr virussequence variationSouth America

Identifiers

PMID40141350
PMCPMC11943181

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.